Initial clinical experience with brinzolamid 1% ophthalmic suspension (Azopt) (CROSBI ID 109643)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Novak-Lauš, Katia ; Iveković, Renata ; Bojić, Lovro ; Koršić, Jadranka ; Zorić-Geber, Mia
engleski
Initial clinical experience with brinzolamid 1% ophthalmic suspension (Azopt)
The aim of this study was to assess the intraocular hypotensive effect of 1% brinzolamide as monotherapy in patients with primary and secondary glaucoma.The six months study included 20 patients of which 19 completed the study.All patients had prevously received local antiglaucoma therapy.Resulst of this study suggested monotherapy with 1.0% brinzolamid to be successful in the regulation of intraocular pressure in patients with primary or secundary glaucoma
carbonic anhydrase inhibitors; glaucoma drug therapy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano